clinical trial · NCT00271817
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
Organon and Co·phase3·completed·n = 1,220
HypercholesterolemiaComparator: ezetimibe/simvastatin + niacin (ER)Comparator: Placebo to ezetimibe/simvastatinComparator: niacin (ER) tabletComparator: ezetimibe (+) simvastatinComparator: Placebo to Niacin (ER)Comparator: ezetimibe/simvastatin and niacin (ER)Comparator: ezetimibe and simvastatinComparator: Placebo to niacin (ER)
brief summary
To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in patients with high cholesterol.
started
Dec 1, 2005
primary completion
Feb 1, 2008
completion
Feb 1, 2008
last updated
May 16, 2024
official title
Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) Co-Administered in Patients With Type IIa or Type IIb Hyperlipidemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol